![Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies | SpringerLink Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00262-021-02897-5/MediaObjects/262_2021_2897_Fig1_HTML.png)
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies | SpringerLink
![Figure 1 | Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology | SpringerLink Figure 1 | Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology | SpringerLink](https://media.springernature.com/full/springer-static/image/art%3A10.1007%2Fs10147-019-01520-z/MediaObjects/10147_2019_1520_Fig1_HTML.png)
Figure 1 | Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology | SpringerLink
![Cancers | Free Full-Text | Development and Radiation Response Assessment in A Novel Syngeneic Mouse Model of Tongue Cancer: 2D Culture, 3D Organoids and Orthotopic Allografts Cancers | Free Full-Text | Development and Radiation Response Assessment in A Novel Syngeneic Mouse Model of Tongue Cancer: 2D Culture, 3D Organoids and Orthotopic Allografts](https://www.mdpi.com/cancers/cancers-12-00579/article_deploy/html/images/cancers-12-00579-ag.png)
Cancers | Free Full-Text | Development and Radiation Response Assessment in A Novel Syngeneic Mouse Model of Tongue Cancer: 2D Culture, 3D Organoids and Orthotopic Allografts
![Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors](https://www.spandidos-publications.com/article_images/or/33/1/OR-33-01-0179-g00.jpg)
Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors
![Frontiers | Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma Frontiers | Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma](https://www.frontiersin.org/files/MyHome%20Article%20Library/499929/499929_Thumb_400.jpg)
Frontiers | Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma
![Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-80216-1/MediaObjects/41598_2020_80216_Fig2_HTML.png)
Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports
![Using Syngeneic Models for the Discovery of Combination Therapy Targets & Predictive Biomarkers of Immunotherapy Efficacy - Drug Discovery World (DDW) Using Syngeneic Models for the Discovery of Combination Therapy Targets & Predictive Biomarkers of Immunotherapy Efficacy - Drug Discovery World (DDW)](https://www.ddw-online.com/media/32/105-figure-1.jpg)
Using Syngeneic Models for the Discovery of Combination Therapy Targets & Predictive Biomarkers of Immunotherapy Efficacy - Drug Discovery World (DDW)
Quantifying spontaneous metastasis in a syngeneic mouse melanoma model using real time PCR - Analyst (RSC Publishing)
MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis | PLOS ONE
![IJMS | Free Full-Text | Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer IJMS | Free Full-Text | Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer](https://www.mdpi.com/ijms/ijms-23-09195/article_deploy/html/images/ijms-23-09195-g001.png)